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Background: Hepatocyte-like cells (iHEPs) generated by transcription factor-mediated direct 
reprogramming of somatic cells have been studied as potential cell sources for the development 
of novel therapies targeting liver diseases. The mechanisms involved in direct reprogramming, 
stability after long-term in vitro expansion and safety profile of reprogrammed cells in different 
experimental models, however, still require further investigation.  
 
Methods: iHEPs were generated by forced expression of Foxa2/Hnf4a in mouse mesenchymal 
stromal cells and characterized their phenotype stability by in vitro and in vivo analyses. 
 
Results: The iHEPs expressed mixed hepatocyte and liver progenitor cell markers, were highly 
proliferative and presented metabolic activities in functional assays. A progressive loss of 
hepatic phenotype, however, was observed after several passages, leading to an increase in 
alpha-SMA+ fibroblast-like cells, which could be distinguished and sorted from iHEPs by 
differential mitochondrial content. The resulting purified iHEPs proliferated, maintained liver 
progenitor cell markers and, upon stimulation with lineage maturation media, increased 
expression of either biliary or hepatocyte markers. In vivo functionality was assessed in 
independent pre-clinical mouse models. Minimal engraftment was observed following 
transplantation in mice with acute acetaminophen-induced liver injury. In contrast, upon 
transplantation in a transgenic mouse model presenting host hepatocyte senescence, widespread 
engraftment and uncontrolled proliferation of iHEPs was observed, forming islands of 
epithelial-like cells, adipocyte-like cells or cells presenting both morphologies.  
 
Conclusion: The results have significant implications for cell reprogramming, suggesting that 
iHEPs generated by Foxa2/Hnf4a expression have an unstable phenotype and depend on 
transgene expression for maintenance of hepatocyte-like characteristics, showing a tendency to 
return to the mesenchymal phenotype of origin and a compromised safety profile. 
 












In vitro generation of functional induced hepatocyte-like cells (iHEPs) could overcome 
some of the hurdles of primary hepatocyte transplantation, including low organ availability and 
limited proliferative potential provided by current culture protocols. In the past decade, somatic 
cells, such as fibroblasts or mesenchymal stromal cells (MSCs), have been directly converted 
into specialized cell types, including hepatocytes1,2. Some of the theoretical advantages of direct 
reprogramming strategies include the use of less time-consuming protocols, avoidance of the 
pluripotency stage and generation of cells with increased maturation profile for personalized 
medicine applications3. In fact, iHEPs generated by direct reprogramming and were shown to 
be amenable for in vitro expansion and able to repopulate the liver when transplanted into 
mice1,2,4.  
Although different reports indicate the potential safety and efficacy of directly 
reprogrammed iHEPs to treat certain pre-clinical models of liver diseases, further studies are 
needed to clarify the mechanisms involved in cell reprogramming and to determine safety and 
phenotype stability after continuous in vitro expansion, before these cells can be applied in a 
clinical setting. Transcription factor-mediated direct reprogramming usually combines forced 
expression of adult hepatocytes genes, such as HNF1 homeobox A (HNF1A) or hepatocyte 
nuclear factor 4 alpha (HNF4A)5, with genes present in early developmental stages, such as 
forkhead box A2 (FOXA2)6.Persistent expression of genes involved in early liver development 
could compromise definitive cell fate, by continuously redirecting the cells towards a progenitor 
phenotype. Moreover, some protocols of direct reprogramming have generated iHEPs 
dependent on transgene expression in order to maintain cell identity, reversing to the cell 
phenotype of origin when exogenous hepatic transcription factor is switched off7. Phenotype 
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stability of reprogrammed cells is a crucial issue for clinical applications, considering that 
billions of in vitro expanded cells would be needed to treat a single patient8. 
Here, we aimed at investigating the safety and phenotype stability of iHEPs after long-
term in vitro expansion in culture. The iHEPs were generated by reprogramming mouse bone 
marrow-derived mesenchymal stromal cells with lentiviral vectors carrying Foxa2 and Hnf4a. 
The vectors utilized herein allow for a straightforward monitoring of transgene expression 
through a reporter gene (GFP) and a selectable marker (puromycin resistance) throughout the 
cell passages. Finally, the safety, efficacy and fate of iHEPs were evaluated in independent in 
vivo liver repopulation experiments.   
MATERIALS AND METHODS 
Isolation and culture of primary cells  
MSCs were isolated from bone marrow of male C57Bl/6 mice, as previously described9. 
The cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 
10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (ThermoFisher Scientific, 
Waltham, MA, USA), with medium changes every 3-4 days, and maintained in an incubator at 
37 °C and humidified atmosphere with 5% CO2. After reaching 80-90% confluency, the cells 
were detached using 0.25% trypsin-EDTA (Sigma-Aldrich, St. Louis, MO, USA), and passaged 
in a 1:3 ratio.   
 Fetal hepatoblasts were isolated from mouse fetal liver (E13.5) as described 
previously10. The isolated hepatoblasts were washed and maintained in culture on Matrigel-
coated plates with William’s medium E (ThermoFisher Scientific). Primary hepatocytes were 




A 2nd-generation lentiviral system was used, and non-replicative lentiviral particles were 
produced by transient transfection of HEK293FT cells with psPAX2 (Addgene #12260), 
pMD2.G (Addgene #12259) and expression vector, at a 2:1:3 ratio, as previously described9. 
Three expression vectors were constructed: pFOXA2IP, pFHIG, and pCWFOXA2. Foxa2 was 
amplified from pGCDNsam_Foxa2 (Addgene #33004) with the primers mmFoxa2_BamHI_F 
and mmFoxa2_BsrGI_R and subcloned between BamHI and BsrGI sites in pEGIP (Addgene 
#26777). For dox-inducible expression studies, Foxa2 was amplified with mmFoxa2_NheI_F 
and mmFoxa2_BamHI_R primers, and subcloned into the pCW-cas9 (Addgene # 50661) Tet-
on expression vector in the NheI/BamHI flanked region. Hnf4a was amplified from 
pGCDNsam_HNF4α (Addgene #33002) with primers mmHnf4a_XbaI_F and 
mmHnf4a_BamHI_R and subcloned into pFUWOSKM (Addgene #20328) vector in the 
XbaI/BamHI flanked region, while IRES-GFP sequence was subcloned in frame, within 
BamHI/AscI restriction sites, after amplification from MSCVPIG (Addgene #18751) using 
IRES-GFP_BamHI_F and IRES-GFP_AscI_R primers. Primers sequences are listed in Table 
S1.      
Generation and expansion of iHEPs  
To generate iHEPs, MSCs were transduced with lentiviral vectors expressing Foxa2 in 
frame with puromycin resistance gene (pFOXA2IP) and Hnf4α in frame with GFP (pFHIG). 
Transduced cells were cultured in DMEM supplemented with 10% FBS and selected by the 
addition of 2 µg/mL puromycin to the culture medium 48 h post lentiviral transduction. After 
72 h, the medium was replaced with iHEP culture medium: DMEM/F-12, 10% FBS, 1% 
penicillin/streptomycin, 0.1 μM dexamethasone (Sigma-Aldrich), 10 mM nicotinamide 
(Sigma-Aldrich), 1% ITS (ThermoFisher Scientific), 10 ng/mL FGF-4, 20 ng/mL HGF, 20 
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ng/mL EGF (Peprotech, Rocky Hill, NJ, USA) and 1 μM SB431542 (Stem Cell Technologies, 
Vancouver, Canada), on Matrigel-coated dishes (Corning, Corning, NY, USA). To generate 
iHEPs with inducible Foxa2 expression vector (pCWFOXA2), 5 μg/mL doxycycline (Sigma-
Aldrich) was added to iHEP medium. The iHEPs were maintained in culture until 90% of 
confluence was reached and were detached using 2x trypsin solution (ThermoFisher Scientific). 
After washing, the cells were resuspended in iHEP medium and re-seeded using a 1:4 split ratio.  
Liver injury experimental models and iHEP transplantation 
All animals received humane care according to the criteria outlined in the “Guide for 
the Care and Use of Laboratory Animals” prepared by the National Academy of Sciences and 
published by the NIH. Four-to-six weeks-old C57Bl/6 male mice were maintained at the animal 
facility of the Center for Biotechnology and Cell Therapy, São Rafael Hospital, under 
controlled conditions of temperature (22 ± 2°C) and humidity (55 ± 10%). The study received 
prior approval by the local Committee of Ethics for the Use of Animals at São Rafael Hospital, 
under the protocol number 01/16. Animal experiments performed at the Centre for Regenerative 
Medicine, Edinburgh were conducted under procedural guidelines, severity protocols and with 
ethical permission from the University of Edinburgh Animal Welfare and Ethical Review Body 
and the UK Home Office. Male and female AhcreMdm2fl/fl mice were on a C57Bl/6J background 
and all animals were housed in specific pathogen-free environment with access to food and 
water ad libitum. 
To model acute-on-chronic disease, male C57Bl/6 mice weighing approximately 20 g 
were exposed to 10% ethanol diluted in drinking water, for three weeks, with access to food ad 
libitum. At the end of the third week, the animals were fasted for 12 h, with free access to water. 
Subsequently, 300 μL of a 450 mg/mL acetaminophen (APAP) solution in heated 0.9% saline 
(40°C) were administered via i.p. injection. After 4 h, 2 x 106 iHEPs cells were resuspended in 
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10 µL of Matrigel (Corning) solution (1:25 dilution) and injected intra-hepatically, a protocol 
that, in a pilot study conducted by our group, resulted in higher engraftment rates when 
compared  to transplantation of iHEPs resuspended in PBS through intrasplenic or intrahepatic 
routes in the APAP model.  
AhcreMdm2fl/fl mice were used to model chronic liver disease and impaired host 
hepatocyte cell regeneration12. Before transplantation, iHEPs underwent external IMPACTTm 
II testing (IDEXX BioAnalytics, Ludwigsburg, Germany) to confirm the absence of infectious 
agents and Mycoplasma contamination. Mice were administered a single dose of β-
Naphthoflavone (βNF) at 20 mg/kg via intraperitoneal injection to activate cre recombinase 1 
week prior to transplantation. 2 x 106 iHEPs were resuspended in 100 μL PBS and transplanted 
by intrasplenic injection, while control mice received PBS alone.  
Immunohistochemistry 
Tissue was fixed in 10% buffered formalin for 8 h and embedded in paraffin for 
sectioning. Sections were dewaxed in xylene and rehydrated in decreasing concentrations of 
ethanol. Tissue underwent heat-induced antigen retrieval for 10 min in Tris-EDTA (pH=9). For 
single chromogenic immunodetection, sections were blocked for endogenous peroxidase and 
avidin/biotin binding sites (Vector Laboratories, Burlingame, CA, USA). Primary antibodies 
were incubated overnight at 4°C at the following concentrations; GFP (Abcam, 1:400), HNF4α 
(Abcam, 1:250), alpha smooth muscle actin (ɑSMA; Sigma-Aldrich, 1:1000), Foxa2 (Abcam, 
Cambridge, UK, ab108422, 1:500), Albumin (Abcam, 1:100), Epithelial cell adhesion molecule 
(EpCAM; Abcam, 1:100) and signal was visualized using avidin-biotin complex methods. For 
immunofluorescent detection, sections were blocked for an hour in protein block (Vector 
Laboratories), primary antibodies were incubated overnight and visualized utilizing Alexa 





Cells were fixed with 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, 
PA, USA) for 15 min, washed twice with PBS for 5 min and permeabilized with 0.1% Triton 
X-100 (Sigma-Aldrich) for 10 min for nuclear antigen labeling. After washing with PBS for 5 
min, blocking was performed using background blocker (Dako, Glostrup, Denmark) for 10 min, 
followed by incubation at 4° C overnight with the following primary antibodies, diluted in 1% 
BSA/PBS (Sigma-Aldrich): anti-albumin (1:500, Dako), anti-Foxa2 (1:100, Santa Cruz 
Biotechnology), anti-CK18 (1:100, Santa Cruz Biotechnology) and anti-e-cadherin (1:100, BD 
Biosciences, San Jose, CA, USA). On the next day, the following secondary antibodies were 
used, in 1:500 dilution: anti-mouse IgG Alexa Fluor 488, anti-rabbit IgG Alexa Fluor 568, anti-
goat IgG Alexa Fluor 488 (all from ThermoFisher Scientific), followed by 1 h incubation at 
RT. Nuclei staining was performed with DAPI (Vector Laboratories). Images were captured 
using an A1+ confocal microscope (Nikon, Tokyo, Japan) or a FluoView 1000 confocal 
microscope (Olympus, Tokyo, Japan).  
Flow-cytometry  
For immunophenotyping, MSCs were incubated for 30 min with the following 
antibodies (diluted 1:100): CD90APC, CD44PE, Sca-1FITC, CD34APC and CD45APC-Cy7 
(BD Biosciences), CD29PE and CD11bPE-Cy5.5 (e-Bioscience, San Diego, CA, USA). At 
least 50,000 events were collected and analyzed with a Fortessa flow cytometer (BD 
Biosciences). For Fluorescence-activated cell sorting (FACS), 1 x 107 iHEPs were stained with 
500 nM MitoTracker Red FM (ThermoFisher Scientific) following the manufacturer’s 
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instructions, and iHEP MT high and iHEP MT low were sorted using the BD FACS Aria II 
(BD Biosciences).  
RT-qPCR 
Total RNA was extracted using TRIZOL® (ThermoFisher Scientific) or RNeasy 
Mini RNA Extraction kit (Qiagen, Hilden, Germany) following the manufacturers’ 
instructions. RNA integrity was assayed by 1% agarose electrophoresis, and purity was 
measured photometrically using the NanoDrop™ 1000 (ThermoFisher Scientific). RNA 
samples (1 μg) were converted to cDNA using High-Capacity cDNA reverse transcription 
kit (ThermoFisher Scientific) or QuantiTect Reverse Transcription (Qiagen). Primer 
sequences are detailed in Table S1. PCR amplification was performed in an ABI7500 Real-
Time PCR System (ThermoFisher Scientific) under standard thermal cycling conditions. 
The threshold cycle method of comparative PCR was used to analyze the results. In some 
experiments, the following commercial primers of Qiagen QuantiTect were used: Albumin 
(Alb; Qiagen, QT00115570), Alpha-fetoprotein (Afp; Qiagen, QT00174020), Epcam (Qiagen, 
QT02304456), Sca-1 (Ly6a; Qiagen, QT00293167), Cytokeratin 19 (Krt19; Qiagen, 
QT00156667), Hnf4a (Qiagen, QT00144739), peptidylprolyl isomerase A (Ppia; Qiagen, 
QT00247709), and in RT-qPCR was performed in a LightCycler 480 II equipment (Roche). 
Gene expression was normalized using the endogenous PPIA gene and the samples were 
amplified in triplicate. The threshold cycle method of comparative PCR was used to analyze 
the results. 
Transmission electron microscopy 
The iHEPs and MSCs were grown in 24-well plates adhered in matrigel-coated plastic 
coverslips (Corning) suitable for ultra-thin cuts until reaching 90% confluency. After this the 
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cells were fixed for 1 h at RT with 1% osmium tetroxide/0.8% potassium ferrocyanide solution 
(Sigma-Aldrich). Subsequently, the material was dehydrated in increasing concentrations of 
acetone (30, 50, 70, 90, and 100%) and included in polybed resin (Polysciences, Washington, 
PA, USA). Ultra-thin sections were obtained from a UC732 ultramicrotome (Leica 
Microsystems, Wetzlar, Hesse, Germany) and collected on 300-mesh copper grids, contrasted 
with uranyl acetate and lead citrate and observed on a transmission electron microscope (JEOL 
JEM -1230) at 15 kV. 
Functional analyses  
For PAS staining, the cells were fixed in a 1:1 acetone / methanol solution at -20 °C for 
20 min and washed twice with distilled water. Then, the cells were incubated in 1% periodic 
acid solution for 10 min at RT. After two washes with distilled water, Schiff reagent was added 
and incubated for 30 min at RT. Finally, distilled water heated at 40°C was used to wash the 
reagent. 
For the indocyanine green (ICG) uptake assay, an ICG solution (Sigma-Aldrich) was 
added to the cultured cells at a final concentration of 1 mg/mL. The cells were incubated at 37 
°C for 1 h, washed three times with PBS, and then cellular uptake of ICG was examined. Next, 
to induce the cellular release of ICG, cells were incubated in culture medium without ICG 
solution at 37 °C for 4 h. For low-density lipoprotein (LDL) uptake assay, the cells were 
incubated with 10 µg/mL acetylated LDL labeled with 1,1’-dioctadecyl-3,3,3’,3’-
tetramethylindo-carbocyanine perchlorate, DiI (DiI-Ac-LDL) (ThermoFisher Scientific) for 4 
h at 37 °C, followed by DAPI staining. For visualization of lipid inclusions, the cells were fixed 
in 4% PFA for 15 min at RT, washed in distilled water and incubated in 70% ethanol for 3 min. 
Finally, cells were stained with Oil red O solution (Sigma-Aldrich) for 5 min and washed with 
70% ethanol.  
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For assessing the expression levels of Cyp450 enzymes, the cells were incubated with 
dexamethasone (100 μM), rifampicin (30 μM), omeprazole (50 μM) or phenobarbital (1 mM) 
for 48 h at 37 °C. Then, the expression of the genes encoding the cytochrome P450, family 3, 
subfamily a, polypeptide 11 (Cyp3a11), cytochrome P450, family 3, subfamily a, polypeptide 
44 (Cyp3a44) and cytochrome P450, family 1, subfamily a, polypeptide 1 (Cyp1a1) enzymes 
was evaluated by RT-qPCR (Table S1). For evaluation of CYP3A4 enzyme activity, the P450-
Glo CYP3A4 assay system kit (Promega, Madison, WI, USA) was used according to the 
manufacturer’s protocol. After incubation at RT protected from light for 30 min, luminescence 
was measured on the GLOMAX 20/20 Luminometer reader (Promega). The luminescence data 
were normalized by the respective total protein concentration per well. 
The bipotent nature of iHEPs was assessed by evaluation of morphology and gene 
expression after incubation with either iHEP media supplemented with the small molecules 0.5 
mM valproic acid, 5 µM parnate and 1 µM TTNPB, or with the maturation media (MM): 
DMEM F12, 10% SBF, 1% penicillin/streptomycin, 10 µM dexamethasone, 10 µM SB431542, 
20 ng/ml oncostatin M, 0.5 mM valproic acid, 5 µM parnate and 1 µM TTNPB. Qiagen 
QuantiTect commercial primers were used: Alb (Qiagen, QT00115570), Afp (Qiagen, 
QT00174020), Aquaporin 1 (Aqp1) (Qiagen, QT00109242), Ppia (Qiagen, QT00247709). 
Gene expression was normalized using the endogenous gene Ppia and samples were amplified 
in triplicate. 
Statistical analysis 
Data were analyzed using Student’s t test or one-way ANOVA followed by Tukey 
or Newman-Keuls multiple comparison tests. Log-rank (Mantel-Cox) test was performed 
for comparison of survival curves. (All data were analyzed using GraphPad Prism v.5.0 
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software (GraphPad Inc., San Diego, CA, USA). Differences were considered statistically 
significant for P values < 0.05. 
RESULTS 
Sustained, high Foxa2 expression is necessary for direct conversion of MSCs to iHEPs  
The MSCs' identity was confirmed by plastic adherence, fibroblastic morphology, and 
potential to differentiate into adipocytes, chondrocytes and osteocytes (Fig. S1A). The cells 
were positive for the MSCs' markers CD90, CD44, CD73, CD29 and Sca-1 and negative for 
hematopoietic markers CD19, CD34 and CD117 (Fig. S1B). Next, we conducted the 
reprogramming protocol (Fig. 1A) and transduced MSCs with lentiviral vectors for constitutive 
expression of Foxa2 and Hnf4a. Treatment with puromycin for 72 h allowed for the selection 
of the cells that were successfully transduced with Foxa2 lentivirus, while GFP expression was 
used as a reporter to detect the cells also transduced with Hnf4a lentivirus (Fig. 1B).   
After 15 days in culture with iHEP medium, large colonies of GFP+ epithelial-like cells 
(iHEPs) were observed and expanded in vitro (Fig. 1B). The cells presented a high proliferative 
rate and were purified from the cells with fibroblastic morphology by successive passages (Fig. 
1C and D). Similar results were obtained by reprogramming MSCs from three different isolates. 
Once visually homogeneous cultures of epithelial-like cells were obtained, the cells were 
characterized. Foxa2 expression was confirmed by immunostaining and positive expression of 
the epithelial marker e-cadherin, and hepatocyte markers albumin and CK-18 were also 
observed (Fig. 1E). RT-qPCR analysis revealed a higher expression of hepatic markers albumin 
and AAT in iHEPs compared to fetal hepatoblasts (E13.5) and parental MSCs, but at lower 
levels than primary hepatocytes. The iHEPs also expressed the early hepatic markers Afp and 
Ck18 at lower levels than fetal hepatoblasts. While Hnf4a expression levels in iHEPs were 
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similar to adult hepatocytes, an increased expression of the immature bipotent progenitor 
marker Krt19 was found in iHEPs (Fig. 1F-K).  
Since Foxa2 expression is high during liver bud formation but falls between E12.5 and 
E15.5 before increasing again in the adult liver13, we hypothesized that persistently high Foxa2 
transgene expression could influence and possibly impair hepatocyte maturation in iHEPs. In 
order to evaluate whether iHEPs could be generated by transient expression of Foxa2, MSCs 
were transduced with a dox-inducible Foxa2 expression vector, along with the Hnf4a 
constitutive expression vector. The addition of doxycycline to the MSC’s culture medium after 
puromycin selection successfully induced the expression of Foxa2 (Fig. 2A). Smaller and less 
frequent epithelial-like colonies were obtained, compared to the previous protocol (Fig. 2B). 
These cells (d-iHEPs) were purified within 6 passages and were found to express CK18 and 
albumin, as shown by immunofluorescence (Fig. 2C), and Foxa2 at similar levels to fetal 
hepatoblasts, but at lower levels when compared to iHEPs, as shown by RT-qPCR (Fig. 2E). 
Moreover, the cells presented a heterogeneous morphology and shifted back to a fibroblastic 
morphology after continuous passaging, cryopreservation and thawing, or after doxycycline 
removal (Fig. 2D and F). Since expandable d-iHEPs were not obtained, the next steps were 
performed using the iHEPs generated with Foxa2 constitutive expression system.  
iHEPs exhibit hepatocyte functions 
After detection of hepatic markers, the functional activities of iHEPs were evaluated. 
ICG clearance can be used for functional analysis of the hepatocyte, since primary hepatocytes 
are able to capture ICG and excrete it in the bile14. The iHEPs were able to uptake ICG after 1 
h incubation and release it 4 h after. Glycogen and lipid storage capacities were detected in 
iHEPs by PAS and Oil red staining, respectively (Fig. 3A). Cholesterol uptake was also 
demonstrated by using a low-density acetylated lipoprotein (Ac-LDL) labeled with a 
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fluorescent probe (Fig. 3B). Drug metabolism ability of iHEPs was evaluated by gene 
expression analysis, showing upregulation of Cyp3a11, Cyp1a1 and Cyp3a44 in iHEPs after 
incubation with dexamethasone, phenobarbital, rifampicin or omeprazole. We also detected 
increased CYP3A4 activity after exposure of iHEPs to the drugs (Fig. 3C and D). 
Epithelial-to-mesenchymal transition of iHEPs in vitro  
In order to evaluate phenotype stability and determine the long-term fate of iHEPs in 
vitro, the cells were maintained in culture for successive passages and cell morphology was 
periodically evaluated. Although CK18, albumin and e-cadherin were detected both in early 
and late-passage iHEPs, increased presence of spindle shaped cells positive for the 
myofibroblast marker a-SMA were found surrounding epithelial-cell like colonies (Fig. 4A-C). 
We hypothesized that these cells could be remnants of non-reprogrammed MSCs, expanded as 
culture contaminants due to ineffective iHEP purification, or alternatively, that these cells could 
be derived from iHEPs that reversed to a mesenchymal phenotype in a process of epithelial-
mesenchymal transition (EMT). Time lapse analysis demonstrated that iHEPs indeed lose their 
epithelial morphology, detaching from neighboring cells in the colony and acquiring a 
fibroblast-like morphology (Fig. 4D). Moreover, low or high passage iHEPs were incubated in 
osteogenic differentiation media and substantial cell death was observed, while surviving cells 
changed morphology and formed areas that were positively stained with Alizarin red, 
confirming osteogenic potential (Fig. 4E and F). Moreover, alizarin red stained area was 
significantly higher in high passage iHEPs, when compared to low passage iHEPs (Fig. 4F). 
Mitochondrial content reflects different cell populations in late iHEP cultures 
Ultrastructural analysis showed that iHEPs have an increased mitochondrial content 
compared to MSCs (Fig. S2A). Therefore, we hypothesized that differential mitochondrial 
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content could be utilized to sort iHEPs from contaminating MSCs by using the viable cell-
compatible fluorescent probe targeting mitochondria (Mitotracker). We found that iHEPs 
present an intermediate level of Mitotracker staining compared to MSCs, which showed low-
level intensity, and to primary hepatocytes, which presented a high-level intensity (Fig. S2B) . 
We also observed a population with low fluorescence level within iHEPs, which may 
correspond to MSCs remnants or cells that underwent EMT.  
To further investigate the characteristics of these different subpopulations, the cells were 
sorted based on Mitotracker staining into populations with high and low intensities (iHEP 
MTHigh and iHEP MTLow). We found significant morphological differences between these 
populations, with iHEP MTHigh cells presenting epithelial-like morphology, and iHEP MTLow 
presenting a fibroblast-like morphology (Fig.5A). GFP expression was also higher in the iHEP 
MTHigh population, along with increased gene expression of Hnfa, Alb, Afp, Epcam and Krt19 
(Fig. 5B), and reduced expression of Sca1 and GFP (Fig. 5B and C).  
In order to confirm the bipotent nature of iHEPs and to determine whether these cells 
could be induced to mature in vitro, we incubated iHEP MTHigh cells with the addition of 
valproic acid, parnate and TTNPB small molecules in the culture media or with a maturation 
media (MM) also supplemented with the same small molecules. After maintaining the cells for 
7 days culture on MM, culture heterogeneity increased when compared to control (Fig. 5D1), 
with the presence of cells with different morphologies, predominantly composed of small cells 
with flattened or cuboidal morphology (Fig. 5D2), but also including islets of cells that resemble 
hepatocytes (Fig. 5D3), presenting high cytoplasm / nucleus ratio, epithelial cell junctions, 
dense cytoplasm and binucleation (Fig. 5D). Gene expression analysis demonstrated that 
incubation with the maturation media was associated with upregulation of either cholangiocyte 
or hepatocyte markers (Fig. 5E).  
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iHEP fate is highly influenced by in vivo signaling 
To evaluate the in vivo cell fate and liver repopulation ability of iHEPs, we induced an 
acute-on-chronic liver injury mouse model caused by APAP intoxication following ethanol 
pretreatment (Fig. 6A). Mice were euthanized either 2 or 14 days after cell infusion for cell 
tracking. The iHEPs were found in 3 out of 5 mice, in the intravascular space, lining endothelial 
cells, 2 days after infusion (Fig. 6B). After 14 days, however, most cells had crossed the 
endothelial barrier and entered liver parenchyma, but with limited repopulation (Fig. 6C). Of 
the engraftment cells, albumin expression was present, but appeared to be lower than resident 
hepatocytes (Fig. 6C). Widespread centrilobular necrosis was seen two days after APAP 
injection, however, after two weeks the liver had completely regenerated, and no morphological 
difference was observed between iHEP-treated and PBS-treated mice (Fig. 6D). No signs of 
tumors or ectopic tissue formation were observed.  
Mouse donor hepatocytes are known to rapidly re-enter cell cycle, proliferate and are 
the major contributors to hepatic regeneration during acute liver injury4. Therefore, we 
performed additional in vivo experiments using the AhCreMdm2fl/fl transgenic mouse model, 
which following induction of hepatocyte senescence, apoptosis and necrosis through 
conditional MDM2 deletion, favors liver repopulation by transplanted cells12. Seven days post-
transplantation, >60% of mice that received iHEPs were found dead despite showing no prior 
clinical signs, and by day 8, the experiment was terminated for humane reasons. None of the 
control PBS-treated mice had become ill for the duration of the experiment but were also 
euthanized for comparison (Fig. 7A and B). Such sudden death is suggestive of fulminant liver 
failure associated with venous occlusion and resulting congestive hepatopathy, as observed at 
necropsy of iHEP treated mice (Fig. 7C). In striking contrast to the acute liver injury model, 
GFP+ iHEPs were identified in all transplanted mice with 6 out of 8 mice demonstrating 
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extensive engraftment. Large islands of cells were identified by H&E staining in the liver and 
spleen (Fig. 7C) and immunostaining with GFP confirmed the iHEP origin (Fig. 7D). The iHEP 
colonies were heterogeneous, displaying epithelial-like morphologies, adipocyte-like 
morphologies or a combination of both (Fig. 7D). Further characterization was performed to 
assess how in vivo signaling may have affected iHEP phenotype. The iHEP colonies retained 
forced overexpression of HNF4ɑ and Foxa2, were largely positive for K19 and contained a 
number of ɑSMA positive cells (Fig. 7E). Interestingly, co-staining with EpCAM highlighted 
a population of dual-positive cells, suggesting that a small proportion showing progenitor-like 
characteristics (Fig. 7E). Similar to APAP-injured mice, iHEPs were found to express albumin 
at lower levels than resident hepatocytes (Fig. 7E).  
   
DISCUSSION  
In the present study, we successfully generated expandable iHEPs by direct 
reprogramming MSCs by forced expression of the transcription factors Foxa2 and Hnf4a. 
Although the iHEPs produced expressed hepatocyte genes and displayed functional activity in 
vitro, these cells were shown by long-term culture to present an unstable identity and a tendency 
to return to a mesenchymal phenotype. Importantly, these cells failed to mature in vivo in a 
transgenic mouse model designed for liver repopulation studies, showing extensive 
proliferative activity and reversed into cells of mesenchymal origin, with detrimental effects to 
the mice.   
Lineage conversion by forced transcription factor expression has challenged the 
concepts of cell plasticity since its pioneer description, in 198715. In the past years, different 
combinations of transcription factors, soluble factors and small molecules were shown to be 
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effective in generating functional iHEPs1,2,4,16-25. Here, we employed the combination of Foxa2 
and Hnf4a, which reproducibly and effectively led to the generation of iHEP colonies. 
Interestingly, the same factors were shown, by in silico analysis of six gene expression 
databases from independent studies, to regulate the expression of a significant number of 
common differentially expressed genes during hepatic direct reprogramming in all samples, in 
both mouse and human cells, irrespectively of the combination of exogenous transcription 
factors utilized26. 
Although the iHEPs generated herein displayed some degree of hepatocyte function, the 
gene expression profile differed from primary hepatocytes, showing a mixed expression of 
immature progenitors and mature hepatocyte markers. This is in accordance with previous 
observations, which also report differences at the epigenetic level comparing iHEPs and 
hepatocytes4,17,19. While extensive work has been done to understand the molecular mechanisms 
involved in somatic cell reprogramming to pluripotency, including the erasure and remodeling 
dynamics of epigenetic marks, little is known about direct reprogramming4,27,29. Future studies 
are necessary to explore the changes of the global epigenome if directly reprogrammed cells 
are to be used in clinical studies. Furthermore, expanded analyses, beyond a panel of phenotypic 
makers, gene expression and standard functional tests may be required to adequately classify 
reprogrammed cells and improve lineage conversion protocols. For instance, deeper analysis of 
iHEPs reprogrammed from fibroblasts revealed an unexpected hindgut identity - or endodermal 
progenitor - in these cells29. 
Here, we demonstrated that sustained expression of both Foxa2 and Hnf4a is necessary 
to reprogram and maintain the iHEPs' phenotype, since high transgenic Hnf4a expression, 
tracked by GFP reporter, was associated with increased hepatocyte gene expression and time-
controlled reduction of transgenic Foxa2 expression led to a reversion to a mesenchymal 
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phenotype. These results suggest that MSCs were not fully reprogrammed and hepatocyte-like 
characteristics acquired by these cells are dependent on sustained expression of the exogenous 
transcription factors. Similar results were recently described for human iHEPs generated using 
a HNF1A-based protocol7. 
MSCs are a good cell source for application in cell therapy, as they are easy to obtain, 
expandable in culture and continue to gain safety data from clinical trials30. We hypothesized 
that MSCs could be reprogrammed to iHEPs with high efficiency, which was confirmed by our 
data, in accordance with previous reports2,31. Here, the iHEP colonies were all composed by 
cells that were successfully transduced with both Foxa2 and Hnf4α, and no colonies appeared 
in MSCs transduced with a single transcription factor or only stimulated with the iHEP medium.  
As well as ensuring identity, purity is one of the minimal criteria for cell-based 
products32. In comparison to iPSCs, which can be clonally expanded indefinitely, iHEPs present 
a high proliferative activity and are usually expanded from a bulk population33. Here, we report 
a method for purification of reprogrammed cells based on mitochondrial staining, advantage of 
the known higher amounts of mitochondria present in hepatocytes, when compared with 
stromal cells34. Interestingly, in vitro dedifferentiation of primary hepatocytes – a process that 
has been well known for many years – is associated with large-scale downregulation of 
mitochondrial proteins35.  
Safety and liver repopulation ability of iHEPs has been demonstrated in different 
studies, using the Fah-/- mouse model1,2,4,16,31. Relatively limited efficacy, however, was found 
when compared to primary hepatocytes. The main advantage of using Fah-/- model is the 
induction of a selective pressure that favors liver repopulation by transplanted cells. However, 
this model is used to mimic type I tyrosinemia, a very rare human disease, and does not 
recapitulate the complex environment of many human liver diseases. Therefore, transplantation 
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of iHEPs should be performed in animal models that represent a spectrum of human liver 
disease to ensure our understanding of how these cells respond to various environmental cues. 
To investigate liver repopulation ability and safety of iHEP transplantation we used here the 
APAP-induced acute liver injury model, as well as the AhCreMdm2fl/fl mouse model, which 
recreates the widespread hepatocyte senescence commonly seen in human chronic liver 
diseases12. Surprisingly, and in contrast to the findings of APAP acute liver injury model, 
uncontrolled and extensive iHEP proliferation was observed, exceeding severity limits within 
a few days. Previously, the same model was used to prove the regenerative capacity of 
transplanted hepatic progenitor cells to restore the liver parenchyma, with no adverse events12. 
These results highlight the significant influence of tissue microenvironment on engraftment, 
proliferation and consequent phenotype of candidate cell therapies. The regenerative niche of 
induced AhCreMdm2fl/fl mice, that previously assisted in the differentiation and maturation of 
primary hepatic progenitor cells into hepatocytes, caused iHEPs to hyper proliferate and 
generate an undefined phenotype. Understanding the unique tissue microenvironments of 
various disease etiologies may aid in identifying the mechanisms that dictate somatic cell 
reprogramming and maturity, with the potential to generate functional cells for clinical cell 
therapy and avoid phenotypic instability. Importantly, it is essential that both the therapeutic 
capacity of candidate cell types and the condition of recipient liver is considered to ensure safe 
and effective cell therapy.  
CONCLUSION 
In summary, the present study revealed that Foxa2/Hnf4a-mediated direct 
reprogramming of MSCs led to the production of expandable iHEPs, which express markers of 
both mature and immature hepatocytes and some degree of hepatic function. In vitro expansion 
of iHEPs, however, showed that these cells are not fully reprogrammed, depend on high 
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expression of exogenous transcription factors, and present a plastic identity, with a tendency to 
return to a mesenchymal phenotype. Moreover, in vivo application of such cells raised safety 
concerns, due to uncontrolled cell proliferation, widespread liver engraftment and generation 
of both hepatic and ectopic mesenchymal derivatives. These results suggest that further direct 
reprogramming protocol optimizations are needed for proper generation of cells that resemble 
hepatocytes, along with careful evaluation and deeper characterization of iHEPs, with special 
attention to the safety evaluation in different animal models, before considering any 
translational cell therapy applications.  
 
ABBREVIATIONS:  
iHEPs- Hepatocyte-like cells. 
MSCs- Mesenchymal stromal cells.  
GFP- Green fluorescent protein.  
ITS- Insulin-transferrin-selenium.  
APAP- Acetaminophen. 
βNF- Naphthoflane. 
ICG- Indocianine green.  
LDL- Low-density protein.  
TTNPB- Arotinoid acid. 
AAT- Alpha 1 antitrypsin. 
AFP- Alpha-fetoprotein.  
CK18- Cytokeratin 18. 
CK19- Cytokeratin 19.  
E12.5- Mouse embryonic day 12.5.   
PAS- Periodic acid-Schiff.  
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αSMA- Alpha-smooth muscle actin.  
EMT- Epithelial-mesenchymal transition.  
MM- Maturation media.  
iPSCs- Induced-pluripotent stem cells.   
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Figure legends 
Figure 1: Generation and phenotypic characterization of iHEPs. Schematic diagram 
depicting the procedure and time-course for the direct conversion of MSCs into iHEPs (A). 
Phase-contrast and fluorescence microscopy images representing MSCs’ morphology before 
hepatic reprogramming and, at reprogramming day 15, the appearance of colonies of epithelial-
like cells with GFP expression.  (B). Phase-contrast image of a purified iHEP culture  and 
respective growth curve at P8 (C). Characterization of iHEPs by immunofluorescence showing 
expression of E-cadherin and FoxA2 (green), albumin and CK18 (red). Nuclei are visualized in 
blue by DAPI staining. Wild-type MSCs were used as controls (D). RT-qPCR analysis of 
MSCs, iHEPs, fetal hepatoblasts (E13.5) and adult primary hepatocytes for hepatic markers 
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(E). Data are shown as mean±SEM of three independent samples for each group. *p<0.05; ** 
p< 0.01; *** p< 0.001. Scale bar: 100 µm.  
 
Figure 2: Direct reprogramming of MSCs to d-iHEPs using dox-inducible Foxa2. 
Schematic diagram depicting the procedure and time-course for the direct conversion of MSCs 
into d-iHEPs (A). Colonies of epithelial-like d-iHEPs (red dashed circles) with GFP expression 
are observed after 15 days of iHEP medium exposure (B). Purified d-iHEPs at passage 6 
expressing the hepatic markers albumin (ALB) and CK18 (green) by immunofluorescence. 
Nuclei are visualized in blue by DAPI staining (C). Increased presence of fibroblast-like cells 
after continuous passaging in the absence of doxycycline (D). RT-qPCR showing decreased 
levels of Foxa2 mRNA in d-iHEPs when compared to iHEPs (E). Validation of Tet-on Foxa2 
system by analysis of Foxa2 expression in iHEPs and d-iHEPs in the presence or absence of 
doxycycline, by RT-PCR (F). *** p< 0.001. Scale bars: 50 µm.  
 
Figure 3:  iHEPs display hepatocyte functions. Functional evaluation of iHEPs compared to 
MSCs, by ICG uptake and release, PAS staining, Oil red O staining (A); LDL uptake evaluation 
(Ac-LDL, seen in red fluorescence), nuclei stained with DAPI (blue) (B); Evaluation of Cyp3a4 
activity in response to 100 μM dexamethasone (iHEP D), 30 μM rifampicin (iHEP R)  or 1 mM 
phenobarbital (iHEP P) (C). RT-qPCR analysis of mRNA expression levels of Cyp450 enzymes 
in response to 100 μM dexamethasone, 30 μM rifampicin, 1 mM phenobarbital or 50 μM 
omeprazole (iHEP O). Expression levels were compared with non-induced iHEPs and MSCs 
(D).   
 
Figure 4.  Long-term expansion of iHEPs is associated with phenotype loss by EMT. Phase 
contrast microscopy images obtained from iHEP cultures at p30, showing the presence of 
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spindle-shaped cells (red dashed circle and arrowheads) surrounding epithelial cells (A). 
Confocal microscopy image showing ɑSMA staining (red) in spindle-shaped cells (B). 
Quantification of fibroblast-like cells basead on ɑSMA staining and high-content image 
morphology analysis, comparing early and late passage iHEPs, using HepG2 hepatoma line as 
control (C).  Sequential time-lapse stills showing a fibroblast-like cell emerging from iHEP 
colony (D). Images of late iHEPs stimulated with osteogenic differentiation medium evaluated 
on D1 and D7 (phase contrast microscopy) and stained for calcium-rich matrix with Azilarin 
red, at D15 (E). Quantification of Alizarin red staining in early and late iHEPs, using HepG2 
hepatoma cell line as control. Bars = 100 μm. * p <0.05; ** p <0.01. 
 
Figure 5.  Mitochondrial content reflects different subpopulations in late iHEP cultures. 
Phase contrast images obtained from iHEP cultures after mitochondrial content-based cell 
sorting for isolation of iHEP MTHigh and iHEP MTLow supopulations. Bars: 100 μm (A). RT-
qPCR analysis of albumin, AFP, HNF4α, Epcam, KRT19 and Sca-1 mRNA levels, comparing 
the two populations. (B). Relation between intensity of GFP fluorescence (Hnf4α-reporter) and 
MitoTracker staining. MTHigh and MTLow iHEPs were labeled with MitoTracker Red FM and 
analyzed by flow cytometry (C). Morphological alterations observed by phase contrast 
microscopy in iHEP MT High subpopulation after being exposed to maturation media for seven 
days. Bar: 100 μm (D). RT-qPCR analysis for quantification of aquaporin-1, Afp and albumin 
mRNAs after maturation protocols. * p <0.05; ** p <0.01; *** p <0.001 (E).  
 
Figure 6.  Evaluation of liver repopulation capacity of iHEPs in APAP acute liver injury 
model. Experimental design (A). Confocal microscopy of liver sections obtained from iHEP-
transplanted mice 48 h (B) or 7 days (C) after cell transplantation. iHEPs are visualized by GFP 
expression (green), while albumin or CD31+ vessels are seen in red. Nuclei were stained with 
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DAPI (blue). Inset shows a detail for observation of Alb/GFP double staining. Scale bars = 100 
µm (B; C, right), 200 µm (C; left), 50 µm (C; middle). Representative images of H&E stained 
liver sections showing extensive areas of centrolobular necrosis 48 h after APAP injection (D; 
left), and complete restoration of normal architecture 7 days after APAP injection (D; right), 
with no signs of ectopic proliferation. 
 
Figure 7. Experimental schematic for iHEP transplantation into AhCreMdm2fl/fl mouse model (A). 
Kaplan-Meier survival plot (B).  Gross morphology and comparative  H&E staining of liver 
and spleen  of iHEP vs PBS transplanted mice (C) and . Confirmation of iHEP engraftment 
showing expression of GFP (, small boxes represent magnified regions), Foxa2 and HNF4ɑ 
(D). Characterization of engrafted iHEPs utilizing dual immunofluorescent staining for GFP 
and ɑSMA , EpCAM or albumin (E). * p <0.05. Scale bars: 200 µm. 
 
Supplemental material 
Figure S1. Characterization of mesenchymal stromal cells. MSCs’ morphology seen by 
phase-contrast microscopy (A), and representative images of tri-lineage differentiation assays 
(B) showing positive staining for Oil Red (adipogenic), Alizarin Red (osteogenic) and Alcian 
Blue (chondrogenic). Flow cytometry analysis with a panel of MSCs and hematopoietic cell 
markers (C). 
 
Figure S2. Differences in mitochondrial content among iHEPs, MSCs and hepatocytes. 
Transmission electron microscopy showing ultrastructure of MSCs and iHEPs (A). M = 
mitochondria; N = Nucleus; L = Lipids. Scale bars = 2 µm. Flow cytometry analysis of iHEPs, 
primary hepatocytes (HEPs) and MSCs stained with Mitotracker (B).   MFI = Median 
fluorescence intensity.  
